{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["28124e3a-5c9c-4e8a-9ed4-7cc9e2b1fdcb", "Q2", 400359646, "HEALTHFUTURES, LLC", 189540, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2009, "second_quarter", "2009-07-16T10:46:32-04:00", 20000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/28124e3a-5c9c-4e8a-9ed4-7cc9e2b1fdcb/\", \"filing_uuid\": \"28124e3a-5c9c-4e8a-9ed4-7cc9e2b1fdcb\", \"filing_type\": \"Q2\", \"filing_type_display\": \"2nd Quarter - Report\", \"filing_year\": 2009, \"filing_period\": \"second_quarter\", \"filing_period_display\": \"2nd Quarter (Apr 1 - June 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/28124e3a-5c9c-4e8a-9ed4-7cc9e2b1fdcb/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"20000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Joyce Briscoe, VP-Administration\", \"dt_posted\": \"2009-07-16T10:46:32-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"600 Maryland Ave, SW\", \"registrant_address_2\": \"Suite 835W\", \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20024\", \"registrant\": {\"id\": 400359646, \"url\": \"https://lda.senate.gov/api/v1/registrants/400359646/\", \"house_registrant_id\": null, \"name\": \"HEALTHFUTURES, LLC\", \"description\": \"Government relations firm\", \"address_1\": \"600 Maryland Ave, SW\", \"address_2\": \"Suite 835W\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20024\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"JENNIFER LEIB\", \"contact_telephone\": \"+1 202-484-1100\", \"dt_updated\": \"2022-04-06T16:07:22.371680-04:00\"}, \"client\": {\"id\": 189540, \"url\": \"https://lda.senate.gov/api/v1/clients/189540/\", \"client_id\": 48, \"name\": \"ASSOCIATION FOR MOLECULAR PATHOLOGY\", \"general_description\": \"Professional Association of Molecular Pathologists\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"MD\", \"state_display\": \"Maryland\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"MD\", \"ppb_state_display\": \"Maryland\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2008-07-21\"}, \"lobbying_activities\": [{\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza\\nH.R. 16991/S 1220, Patient Access to Critical Lab Tests Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 45362, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROBERT\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WELLS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 48152, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"JENNIFER\", \"nickname\": null, \"middle_name\": \"RACHEL\", \"last_name\": \"LEIB\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Health Care Reform in general\\nIssues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza\\nH.R. 16991/S 1220, Patient Access to Critical Lab Tests Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 45362, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ROBERT\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WELLS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 48152, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"JENNIFER\", \"nickname\": null, \"middle_name\": \"RACHEL\", \"last_name\": \"LEIB\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["28124e3a-5c9c-4e8a-9ed4-7cc9e2b1fdcb"], "units": {}, "query_ms": 3.8635898381471634, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}